Get In Touch

Paraneoplastic syndromes are an umbrella of uncommon nervous system disorders that develop mainly in patients suffering from cancer. Paraneoplastic syndromes can also affect other organs such as joints, blood (hematologic), endocrine system, and skin (dermatologic). Paraneoplastic syndromes can be classified into categories such as cerebellar degeneration, limbic encephalitis, encephalomyelitis, opsoclonus-myoclonus, stiff person syndrome, myelopathy, Lambert-Eaton myasthenic syndrome, myasthenia gravis, neuromyotonia, peripheral neuropathy, and dysautonomia.

Common symptoms of paraneoplastic syndromes include difficulty in maintaining balance, loss of fine motor skills such as picking up objects, slurred speech or stuttering, hallucinations, vision problems, difficulty swallowing, unusual involuntary movements, loss of muscle tone or weakness, sleep disturbances, memory loss and other cognitive impairment, loss of muscle coordination, and seizures. Paraneoplastic syndromes are not caused by cancer cells directly disrupting nerve function. Scientists believe that paraneoplastic syndromes are caused by particular antibodies and T cells. Paraneoplastic syndromes are a major risk to the lymphatic system, ovaries, testicals, breasts, and lungs.

Clinical history and blood tests primarily focus on diagnosing paraneoplastic syndromes.  Neurologist ask some general physical questions to diagnose paraneoplastic syndromes. Doctors conduct simple test for reflexes, muscle strength, mood, sense of touch, coordination, memory, muscle tone, balance, vision, and hearing. Doctors also recommended laboratory tests (blood test, lumbar puncture), imaging tests (PET plus CT, magnetic resonance imaging, positron emission tomography, and computerized tomography).

Increase in the prevalence of cancer worldwide is anticipated to boost the paraneoplastic syndromes market during the forecast period. Rise in fuel prices is boosting government revenue in Middle East & Africa, which, in turn, is augmenting the development of health care infrastructure. High incidence of liver diseases across emerging economies in regions such as Asia Pacific, Latin America, and Eastern Europe is a leading factor boosting the paraneoplastic syndrome market in these regions. The development of the market across these regions is estimated to be a key determinant of the growth of the global paraneoplastic syndromes market.

The global paraneoplastic syndromes market can be segmented based on syndrome, treatment, end-user, and region. In terms of syndrome, the market can be calssified into cerebellar degeneration, limbic encephalitis, encephalomyelitis, opsoclonus-myoclonus, stiff person syndrome, myelopathy, Lambert-Eaton myasthenic syndrome, myasthenia gravis, neuromyotonia, peripheral neuropathy, and dysautonomia.

Based on treatment, the paraneoplastic syndromes market can be categorized into medications and therapies. Corticosteroids, anti-seizure medications, immunosuppressants, and muscle transmission are common medications. Physical therapy and speech therapy help to restore muscle function.

In terms of end-user, the global paraneoplastic syndromes market can be segmented into hospitals, specialized clinics, and others. In terms of revenue, the hospitals segment held a significant share of the market in 2017.

Based on region, the global paraneoplastic syndromes market can be segmented into North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America accounted for a significant share of the global market in 2017, followed by Europe and Asia Pacific. The U.S. held a major share of the market in North America in terms of revenue. The market in Asia Pacific is expanding rapidly due to an increase in the number of patients. Moreover, Asia Pacific is projected to be a highly attractive region of the market in the near future. This is due to the presence of emerging economies such as India, China, and Japan.Moreover, factors such as better health care infrastructure, economic growth, rise in the number of insurance payers, expanding and developing private health care sector, and increase in awareness among people are expected to propel the market in the region.

Key players operating in the global paraneoplastic syndromes market include Astellas Pharma Inc., Abbott Laboratories, Bristol-Myers Squibb, Gilead Sciences, Glaxosmithkline Plc, F. Hoffmann-La Roche Ltd, merck & co. Inc, Novartis Ag, Sanofi S.A, Pfizer Inc., and Takeda Pharmaceutical.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Paraneoplastic Syndromes Market